jack14 Posted November 22, 2020 Share Posted November 22, 2020 I had a CT scan done on the 18th after four rounds of Keytruda for Stage four NSCLC. It was compared to a CT scan that was done in July. The primary site, a right lung nodule, has remained stable at 9mm in size. The left subpectoral lymph node is slightly larger at 1.8 cm (from 1.4 cm). The left supraclavicular node has went from 1.0 cm to "Asymmetric nodular soft tissue in the left supraclavicular region, extending into the high left subpectoral region, appears more prominent than on 07/30/2020". My CA 19-9 marker has been dropping from 76 originally to 54 when this CT scan was done, and all labs are unremarkable. My Oncologist has advised that we continue this line of treatment, I agreed and had my 11th infusion. Anyway, I just accessed my report through the portal and I was wondering what the radiologist means regarding the supraclavicular change from a 1.0 cm lymph node to "Asymmetric nodular soft tissue in the left supraclavicular region, extending into the high left subpectoral region"? PS I am hoping that maybe the enlarged node is pseudo-progression and the other one has dissolved and left an area of inflammation? Thank you Link to comment Share on other sites More sharing options...
This topic is now archived and is closed to further replies.